Metformin Hydrochloride; Rosiglitazone Maleate Patent Expiration
Metformin Hydrochloride; Rosiglitazone Maleate is Used for managing and treating type 2 diabetes mellitus. It was first introduced by Sb Pharmco Puerto Rico Inc
Metformin Hydrochloride; Rosiglitazone Maleate Patents
Given below is the list of patents protecting Metformin Hydrochloride; Rosiglitazone Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avandamet | US8236345 | Composition and use |
Oct 07, 2022
(Expired) | Sb Pharmco |
| Avandamet |
US7358366 (Pediatric) | Thiazolidinedione derivative and its use as antidiabetic |
Oct 19, 2020
(Expired) | Sb Pharmco |
| Avandamet | US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
Apr 19, 2020
(Expired) | Sb Pharmco |
| Avandamet |
US6288095 (Pediatric) | Compounds |
Aug 11, 2017
(Expired) | Sb Pharmco |
| Avandamet | US6288095 | Compounds |
Feb 11, 2017
(Expired) | Sb Pharmco |
| Avandamet | US5965584 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Sb Pharmco |
| Avandamet | US6166042 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Sb Pharmco |
| Avandamet |
US5741803 (Pediatric) | Substituted thiazolidinedionle derivatives |
Oct 21, 2015
(Expired) | Sb Pharmco |
| Avandamet | US5741803 | Substituted thiazolidinedionle derivatives |
Apr 21, 2015
(Expired) | Sb Pharmco |
Metformin Hydrochloride; Rosiglitazone Maleate's Family Patents
Explore Our Curated Drug Screens
Metformin Hydrochloride; Rosiglitazone Maleate Generic API Manufacturers
Several generic applications have been filed for Metformin Hydrochloride; Rosiglitazone Maleate.
Given below is the list of companies who have filed for Metformin Hydrochloride; Rosiglitazone Maleate generic, along with the locations of their manufacturing plants worldwide.
1. TEVA
Teva Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Metformin Hydrochloride; Rosiglitazone Maleate. All of these versions come by the name ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 7, 2014 |
| 500MG; EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 7, 2014 |
| 1GM; EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 7, 2014 |
| 1GM; EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 7, 2014 |
| 500MG; EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | May 19, 2017 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||